Showing results (1121-1130 of 1,857) with videos related to

Sort By:
Pageof 186
JAMA Ophthalmology|May 13, 2022
Potentially Missed Opportunities in Prevention of Acute Angle-Closure CrisisAnnie M Wu, Joshua D Stein, Manjool Shah
JAMA Ophthalmology|June 2, 2022
Association Between Retinal Microanatomy in Preterm Infants and 9-Month Visual AcuityKai R Seely, Shwetha Mangalesh, Liangbo L Shen, et al.
JAMA Ophthalmology|January 6, 2018
Association of Functional Loss With the Biomechanical Response of the Optic Nerve Head to Acute Transient Intraocular Pressure ElevationsTin A Tun, Eray Atalay, Mani Baskaran, et al.
JAMA Ophthalmology|January 6, 2018
Effectiveness of a Binocular Video Game vs Placebo Video Game for Improving Visual Functions in Older Children, Teenagers, and Adults With Amblyopia: A Randomized Clinical TrialTina Y Gao, Cindy X Guo, Raiju J Babu, et al.
JAMA Ophthalmology|December 14, 2018
Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical TrialsLois E H Smith, Ann Hellström, Andreas Stahl, et al.
JAMA Ophthalmology|December 21, 2018
Association of Age-Related Macular Degeneration With Risk of All-Cause and Specific-Cause Mortality in the National Health and Nutrition Examination Survey, 2005 to 2008Zhuoting Zhu, Wei Wang, Stuart Keel, et al.
JAMA Ophthalmology|December 21, 2018
Oculomotor Response to Cumulative Subconcussive Head Impacts in US High School Football Players: A Pilot Longitudinal StudySteven W Zonner, Keisuke Ejima, Ciara C Fulgar, et al.
JAMA Ophthalmology|March 16, 2018
Validation of the Colorado Retinopathy of Prematurity Screening ModelEmily A McCourt, Gui-Shuang Ying, Anne M Lynch, et al.
JAMA Ophthalmology|February 25, 2018
Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical TrialIngrid U Scott, Paul C VanVeldhuisen, Michael S Ip, et al.
JAMA Ophthalmology|June 16, 2022
Cost of Ranibizumab Port Delivery System vs Intravitreal Injections for Patients With Neovascular Age-Related Macular DegenerationShefali Sood, Jordan Mandell, Arjun Watane, et al.
Pageof 186